首页> 外国专利> POLYMERIC MICELLE COMPLEXES OF LOW MOLECULAR WEIGHT ANTITUMOR AGENTS AND STYRENE MALEIC ACID COPOLYMERS

POLYMERIC MICELLE COMPLEXES OF LOW MOLECULAR WEIGHT ANTITUMOR AGENTS AND STYRENE MALEIC ACID COPOLYMERS

机译:低分子量抗静电剂和苯乙烯马来酸共聚物的聚合物胶束复合物

摘要

The present invention relates to polymeric antitumor agents in whichpolymeric complex micelle structures are formed by intermolecular binding ormutual interaction between styrene maleic acid copolymer (SMA) and a lowmolecular antitumor agent which is an anthracyclin drug such as pirarubicin,doxorubicin, epirbicin, daunorbicin, aclarubicin, or alkaloid antitumor agentsuchas cis-platinum or taxol.These polymeric micelle antitumor agents may improve selectiveaccumulation of drugs to cancer tissue for improved antitumor effect, whileconcentrating less at normal organs or tissues, so that a lesser adverseeffect maybe accomplished.These polymeric antitumor agents may be prepared by dissolvingSMA and a low molecular antitumor agent in aqueous solution, then in thepresence of aqueous soluble carbodiimide, amino acids, or polyamine, adjustingpH to form micelle complexes, and separating and recovering the polymericmicelle component.
机译:本发明涉及聚合物抗肿瘤剂,其中高分子复合胶束结构是通过分子间结合或苯乙烯马来酸共聚物(SMA)与低聚物之间的相互作用分子抗肿瘤药,是蒽环类药物,例如吡柔比星,阿霉素,表皮霉素,柔红霉素,阿克拉霉素或生物碱抗肿瘤药这样如顺铂或紫杉醇。这些聚合的胶束抗肿瘤剂可以改善选择性药物向癌组织蓄积,以提高抗肿瘤效果,而较少集中在正常器官或组织上,从而减少了不良反应效果可能完成。这些聚合抗肿瘤剂可以通过溶解制备SMA和一种低分子抗肿瘤药先溶于水溶液,然后在水溶性碳二亚胺,氨基酸或多胺的存在,调节pH形成胶束复合物,并分离和回收聚合物胶束成分。

著录项

  • 公开/公告号CA2489259C

    专利类型

  • 公开/公告日2011-08-30

    原文格式PDF

  • 申请/专利权人 MAEDA HIROSHI;

    申请/专利号CA20042489259

  • 发明设计人 MAEDA HIROSHI;GREISH KHALED;

    申请日2004-02-02

  • 分类号A61K47/48;A61K9/51;A61K33/24;A61K45/06;A61K47/18;A61K47/32;A61P35;

  • 国家 CA

  • 入库时间 2022-08-21 18:02:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号